
Getinge ( ($SE:GETI.B) ) just unveiled an update. Getinge has established a Sustainable Financing Framework for green or social financing of eligible projects with environmental or social benefits. Sustainable Fitch
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| GNGBF | ― | ― | ― | 24.25% |
| Name | Price | % Change | |
|---|---|---|---|
| ― | +24.25% |

Getinge ( ($SE:GETI.B) ) just unveiled an update. Getinge has established a Sustainable Financing Framework for green or social financing of eligible projects with environmental or social benefits. Sustainable Fitch

The latest announcement is out from Getinge ( ($SE:GETI.B) ). Getinge is a medical technology company serving hospitals and life science institutions with products for intensive care, cardiovascular procedures, operating

Getinge ( ($SE:GETI.B) ) has provided an update. Getinge has announced that Elin Frostehav will step down as President of Acute Care Therapies and leave the executive team to pursue

JPMorgan analyst David Adlington raised the firm’s price target on Getinge (GNGBY) to SEK 193 from SEK 165 and keeps an Underweight rating on the shares. Published first on TheFly

Getinge ( ($SE:GETI.B) ) just unveiled an update. Getinge reported organic growth in net sales and order intake in the third quarter of 2026, with Acute Care Therapies leading sales

Getinge AB (UK) (0GZV) is scheduled to report 3rd quarter earnings on 10/21/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Getinge AB (UK) to post earnings

An announcement from Getinge ( ($SE:GETI.B) ) is now available. Getinge has appointed its Nomination Committee ahead of the 2027 Annual General Meeting in line with its governance principles, naming

The latest update is out from Getinge ( ($SE:GETI.B) ). Getinge AB announced that Eric Honroth will step down as President Life Science and leave the executive management team to

Getinge ( ($SE:GETI.B) ) just unveiled an update. Swedish medtech group Getinge has announced that it will publish its third-quarter 2026 financial report on October 21 at 08:00 a.m. CEST,

Pareto analyst Christian Lee downgraded Getinge (GNGBY) to Hold from Buy with an unchanged price target of SEK 255. The firm cites the company’s tough compares for the downgrade. Published
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.